TickerTalks
Browse all tickers →
TickerTalks›$AHG
AHAHG

Akso Health Group

$AHG·$1.1B·Medical - Distribution·Healthcare
$1.35-1.8%YTD-19.2%1Y-22.0%
Price updated 11h ago·X counts updated 4d ago
AHAHG
$AHGAkso Health Group
$1.35-1.83%22 posts
AI analysisFundamentalsVoices on X
Loading…

On X

The complete picture of $AHG on X — how loud the conversation is right now, how it has trended over the last two weeks, and which way the crowd is leaning.

22X posts · last 7 days
Sep 28Oct 11

AI verdictAI analysisGenerated by AI from underlying data

TickerTalks' own read on what's driving $AHG — fundamentals, momentum, or an event — and whether it agrees with the X crowd.

Broken storySelling offAI verdict · as of 2026-10-02

Falling on heavy selling — points lower unless it turns around.

Chinese social-e-commerce microcap at $1.02 with Q4 FY26 revenue -13% YoY, operating margin -282% and shares down 39% YTD.

Akso Health Group operates the Xiaobai Maimai mobile social e-commerce platform in China across food, apparel and lifestyle categories, so revenue depends on user-platform engagement and transaction volume.

  • Q4 FY26 revenue $3.42M, -12.9% YoY with -282% operating margin and EPS -$0.03; prior quarters: Q3 FY26 $3.42M (-1.5%) at -282% margin; Q2 FY26 $3.50M (+0.9%) at -21% margin; Q4 FY25 $3.92M (+416%) at -2113% margin
  • TTM: -3.4x earnings (negative), 54x sales (nominal), -50% ROE, -3.9% gross margin, -7.2% operating margin, FCF yield -2.1%, debt-to-equity 0.002
  • FY26 (ending Mar) estimate: $108.3M revenue, $4.02 EPS — single-coverage data likely nominal error against the actual operating base
  • YTD -39%, trailing-12m -39% at $1.02 against a $769M market cap — significant disconnect between tiny operating line and $769M market cap

The equity is a US-listed Chinese microcap with tiny operating revenue, persistent operating losses and a $769M market cap that implies substantial float-driven pricing rather than fundamental valuation.

What to watch: Dec 2 Q1 FY27 earnings — whether operating revenue stabilizes above the current $3.5M quarterly level or extends the decline.

On the calendar: 2026-12-02 Q1 FY27 earnings

Read the AI verdict on $AHG

  • One-line verdict on what's driving the move — fundamentals, momentum, both, or an event
  • Next dated catalyst when there is one (earnings, deal closing, activist clock)
  • Whether TickerTalks' read agrees with or diverges from the X crowd
Free, forever. No credit card.

What it does

Plain-English summary of the business — what they sell and how they make money.

Akso Health Group, together with its subsidiaries, operates a social e-commerce mobile platform in the People’s Republic of China. It operates Xiaobai Maimai App, a social e-commerce mobile platform that offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment products, housewares, home appliances, and cost-saving promotions at petrol gas stations. The company also sells medical devices, such as defibrillators and anesthesia laryngoscopes. In addition, it provides health treatment, consultancy support, and marketing promotion services, as well as technological promotion services and import and export. The company was formerly known as Xiaobai Maimai Inc. and changed its name to Akso Health Group in December 2021. Akso Health Group was founded in 2014 and is headquartered in Qingdao, China.

Industry overviewAI analysisGenerated by AI from underlying data

Where Medical - Distribution sits in its cycle right now — and what that implies for $AHG.

Medical - Distribution · Healthcare

Healthcare supply chain normalization after COVID disruptions is stabilizing distributor margins, while specialty drug distribution (biologics, oncology) is the primary growth segment with higher gross margin per unit than commoditized generics. Group purchasing organization contract cycles and hospital system M&A concentrate purchasing power, pressuring distribution fee structures.

Top industry ETF

$XLVHealth Care Select Sector SPDR
+9.0%YTD
+24.3%1Y

Fundamentals & catalyst

Profitability, valuation, and the next earnings event — at a glance, with rule-of-thumb signals.

Key ratios

P/E
-3.4How much investors are paying per dollar of profit the company actually earned in the last 12 months. Lower means the stock looks cheaper relative to earnings.~15–25 is typical for the S&P 500; high-growth names trade 30+; hyper-growth or speculative can be 100+ or negative.
ROIC
-56.7%What percentage return the business earns on every dollar of capital (equity + debt) deployed in operations. The cleanest measure of business quality.Above ~15% is high-quality; consistently above 25% suggests a real moat. Below the company's cost of capital is value-destroying.
Op margin
-7.2%Operating profit (after sales, marketing, R&D, and overhead but before interest and taxes) as a percentage of revenue. The clearest view of how well the underlying business is run.Mature business above 20% is healthy; software businesses can run 30%+; commodity / retail businesses operate in single digits.
FCF yield
-2.1%Free cash flow (operating cash flow minus capex) divided by the company's market cap. The cash-on-cash return you'd get owning the whole business at today's price.Above ~5% is attractive; below ~2% means you're paying up for growth. Capital-light businesses (software) run higher than capital-heavy ones (utilities).
P/S
53.9Same idea as P/E but per dollar of revenue. Useful for companies that aren't profitable yet, where P/E is meaningless.Under ~2 is cheap; software / SaaS often runs 8–15; well above 20 implies the market is pricing in very high future growth.
ROE
-50.2%Net income as a percentage of shareholders' equity. Similar to ROIC but counts only the equity side.Above 20% is strong, but can be inflated by leverage — a heavily indebted company can show high ROE with weak underlying ROIC.
Gross margin
-3.9%Revenue minus the direct cost of producing what was sold, as a percentage of revenue. The first read on whether the product is structurally profitable.Software / SaaS is typically 70%+; consumer goods 30–50%; commodity / hardware businesses can be under 20%.
D/E
0.0Total debt divided by shareholders' equity. Measures how much the business runs on borrowed money versus owner capital.Under 1 is conservative; 1–2 is typical for mature businesses; over 2 is leveraged and more sensitive to interest rates.

Past earnings

QuarterReportedActualEstimateSurprise
Q1 2026Jun 16, 2026$-0.03——
Q4 2025Feb 10, 2026$-0.03——
Q3 2025Nov 13, 2025$-0.00——
Q1 2025Apr 30, 2025$-0.20$-0.18-11.2%
Next earningsWed, Dec 2

Quarterly trend

QuarterRevenueYoYGrossOpEPSFCF
Q4 FY26$3.4M-12.9%-9.3%-282%$-0.03$-12.8M
Q3 FY26$3.4M-1.5%-9.3%-282%$-0.03$80.8M
Q2 FY26$3.5M+0.9%8.9%-20.5%$-0.00$-87.2M
Q4 FY25$3.9M+415.8%-6.0%-2113%$-0.20$3.0M

Forward consensus

5-year forecast · up to 1 analysts
FYRevenueRangeEPSRangeAnalysts
FY26$108.3M$108.3M – $108.3M$4.02$4.02 – $4.021
FY27$108.3M$108.3M – $108.3M$4.02$4.02 – $4.021
FY28$66.6M$66.6M – $66.6M-$0.12-$0.12 – -$0.121
FY29$35.4M$35.4M – $35.4M-$0.36-$0.36 – -$0.361
FY30$98.9M$98.9M – $98.9M$2.58$2.58 – $2.581

Setup & momentum

Volume, range, and moving-average position — the technical setup driving short-term moves.

Right now

Vol vs 30dToday's traded share volume divided by the average over the prior 30 trading days. ≥3× signals unusual interest; below 1× is quiet.0.0×Today's traded share volume divided by the average over the prior 30 trading days. ≥3× signals unusual interest; below 1× is quiet.
52w rangeWhere the latest close sits between the 52-week low (0%) and high (100%). Above 80% is extended; below 30% is basing or in a downtrend.37%Where the latest close sits between the 52-week low (0%) and high (100%). Above 80% is extended; below 30% is basing or in a downtrend.
vs 50d MALatest close vs the 50-day simple moving average. Positive = short-term trend is up.+33.9%Latest close vs the 50-day simple moving average. Positive = short-term trend is up.
vs 200d MALatest close vs the 200-day simple moving average. Positive = long-term trend is up.-11.4%Latest close vs the 200-day simple moving average. Positive = long-term trend is up.

Float & profile

FloatLow float · 10.4M shFree-float shares — the slice of issued stock actually available to trade. Lower buckets squeeze harder on a catalyst.Traded today0.0% of floatToday's volume as a percent of the free float. Above 5% on a single day is unusually high turnover for the available share count.β-1.005-year weekly beta vs the S&P 500. Above 1.5 means the stock typically moves more than the index; below 0.8 moves less.

SEC filings

Material 8-K, 13D, S-3, and 424B5 events from the last 180 days — the filings that actually move the price.

No material 8-K / SC 13D / S-3 / 424B5 filings in the last 180 days.

+ 2 other (1 20-F · 1 6-K) in window

More in Medical - Distribution

Peers in the same group — one click to compare setups, fundamentals, and chatter.

$CAH
Voices on X · last 7 days

No standout posts about $AHG on X in the last 7 days.

TickerTalks is a research tool, not financial advice. We surface social-attention data; we do not make stock recommendations. Past attention is not predictive of future price movements.

PrivacyTermsSupport